New sensor could help doctors drain fluid from heart failure Patients' lungs
NCT ID NCT07600398
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a wearable sensor that measures lung fluid can help doctors better treat fluid buildup in patients hospitalized for acute heart failure. About 216 adults will be randomly assigned to either standard care or care guided by the sensor. The goal is to see if the sensor-guided approach reduces the risk of death, rehospitalization, or urgent heart failure visits within 30 days after discharge.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remote Dielectric Sensing (ReDS) device
What this could lead to
If it works, this could give doctors a simple, non-invasive tool to better manage fluid levels in heart failure patients, potentially reducing hospital readmissions.
What could go wrong
This is a relatively small, early-stage trial (216 participants) testing a device, not a drug. The benefit may be modest or not statistically significant, and results may not apply to all heart failure patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE (AHF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto Cardiovascular de Buenos Aires
Buenos Aires, Buenos Aires, 1428, Argentina